Literature DB >> 23448496

The chicken hypersensitivity site 4 core insulator blocks promoter interference in lentiviral vectors.

Naoya Uchida1, Hideki Hanawa, Motoko Yamamoto, Takashi Shimada.   

Abstract

Lentiviral vectors, including double internal promoters, can be used to express two transgenes in a single vector construct; however, transcriptional activities from double internal promoters are often inhibited by promoter interference. To determine whether the chicken hypersensitivity site 4 insulator (cHS4) could block promoter interference, lentiviral vectors including an MSCV-U3 promoter (Mp) and an EF1α promoter (Ep) were generated, and transgene expression was evaluated among transduced cells. In the Ep-Mp configuration, transcriptional activity from Mp was much lower, while Mp-Ep had similar transcription levels from both promoters. The cHS4 core insulator increased expression levels from Mp in HeLa cells, hematopoietic cell lines, and mouse peripheral blood cells following hematopoietic stem cell transplantation transduced with the Mp-Ep configured vector. This blocking function was mainly mediated by barrier activity regions in the insulator but not by CCCTC-binding factor (CTCF) binding sites. Cytosine-phosphate-guanine (CpG) methylation did not contribute to this barrier activity. In summary, combining the cHS4 insulator in double promoter vectors can improve transgene expression levels in various cell lines and mouse hematopoietic repopulating cells. These findings are useful for developing hematopoietic stem cell gene therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448496      PMCID: PMC3732123          DOI: 10.1089/hgtb.2012.152

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  24 in total

1.  Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.

Authors:  D S Steinwaerder; A Lieber
Journal:  Gene Ther       Date:  2000-04       Impact factor: 5.250

2.  Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells.

Authors:  Israel Ben-Dor; Pavel Itsykson; Daniel Goldenberg; Eithan Galun; Benjamin E Reubinoff
Journal:  Mol Ther       Date:  2006-04-24       Impact factor: 11.454

3.  Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.

Authors:  Xiaobing Yu; Xiangcan Zhan; Jenice D'Costa; Vivek M Tanavde; Zhaohui Ye; Tien Peng; Matthew T Malehorn; Xiaoming Yang; Curt I Civin; Linzhao Cheng
Journal:  Mol Ther       Date:  2003-06       Impact factor: 11.454

4.  Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.

Authors:  Franck P Dupuy; Enguerran Mouly; Mariana Mesel-Lemoine; Céline Morel; Julien Abriol; Mustapha Cherai; Claude Baillou; Didier Nègre; François-Loïc Cosset; David Klatzmann; François M Lemoine
Journal:  J Gene Med       Date:  2005-09       Impact factor: 4.565

5.  Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulation.

Authors:  N J Proudfoot
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

6.  Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy.

Authors:  P de Felipe; V Martín; M L Cortés; M Ryan; M Izquierdo
Journal:  Gene Ther       Date:  1999-02       Impact factor: 5.250

7.  Murine retroviral but not human cellular promoters induce in vivo erythroid-specific deregulation that can be partially prevented by insulators.

Authors:  Elodie Robert-Richard; Emmanuel Richard; Punam Malik; Cécile Ged; Hubert de Verneuil; François Moreau-Gaudry
Journal:  Mol Ther       Date:  2007-01       Impact factor: 11.454

8.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

9.  Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element.

Authors:  Paritha I Arumugam; Jessica Scholes; Natalya Perelman; Ping Xia; Jiing-Kuan Yee; Punam Malik
Journal:  Mol Ther       Date:  2007-07-10       Impact factor: 11.454

10.  Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects.

Authors:  Mari Aker; Julie Tubb; Amy C Groth; Anatoly A Bukovsky; Adam C Bell; Gary Felsenfeld; Hans-Peter Kiem; George Stamatoyannopoulos; David W Emery
Journal:  Hum Gene Ther       Date:  2007-04       Impact factor: 5.695

View more
  12 in total

1.  Genomic discovery of potent chromatin insulators for human gene therapy.

Authors:  Mingdong Liu; Matthew T Maurano; Hao Wang; Heyuan Qi; Chao-Zhong Song; Patrick A Navas; David W Emery; John A Stamatoyannopoulos; George Stamatoyannopoulos
Journal:  Nat Biotechnol       Date:  2015-01-12       Impact factor: 54.908

2.  Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response.

Authors:  Marija Vujadinovic; Kerstin Wunderlich; Benoit Callendret; Marina Koning; Mark Vermeulen; Barbara Sanders; Esmeralda van der Helm; Adile Gecgel; Dirk Spek; Karin de Boer; Masha Stalknecht; Jan Serroyen; Maria Grazia Pau; Hanneke Schuitemaker; Roland Zahn; Jerome Custers; Jort Vellinga
Journal:  Hum Gene Ther       Date:  2017-11-30       Impact factor: 5.695

3.  Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model.

Authors:  N Uchida; R P Weitzel; M E Evans; R Green; A C Bonifacino; A E Krouse; M E Metzger; M M Hsieh; R E Donahue; J F Tisdale
Journal:  Gene Ther       Date:  2013-11-21       Impact factor: 5.250

4.  Chicken β-globin insulators fail to shield the nkx2.5 promoter from integration site effects in zebrafish.

Authors:  Viktorija Grajevskaja; Jorune Balciuniene; Darius Balciunas
Journal:  Mol Genet Genomics       Date:  2013-09-14       Impact factor: 3.291

5.  Increased Specific Labeling of INS-1 Pancreatic Beta-Cell by Using RIP-Driven Cre Mutants with Reduced Activity.

Authors:  Gen-cheng Gong; Wen-zhu Fan; Di-zheng Li; Xiong Tian; Shao-jun Chen; Yu-cai Fu; Wen-can Xu; Chi-ju Wei
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

6.  Spontaneous reactivation of latent HIV-1 promoters is linked to the cell cycle as revealed by a genetic-insulators-containing dual-fluorescence HIV-1-based vector.

Authors:  Yik Lim Kok; Stefan Schmutz; Anne Inderbitzin; Kathrin Neumann; Audrey Kelley; Lisa Jörimann; Mohaned Shilaih; Valentina Vongrad; Roger D Kouyos; Huldrych F Günthard; Christian Berens; Karin J Metzner
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

7.  Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders.

Authors:  Naoya Uchida; Matthew M Hsieh; Lydia Raines; Juan J Haro-Mora; Selami Demirci; Aylin C Bonifacino; Allen E Krouse; Mark E Metzger; Robert E Donahue; John F Tisdale
Journal:  Nat Commun       Date:  2019-10-02       Impact factor: 14.919

8.  Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction.

Authors:  Naoya Uchida; Matthew M Hsieh; Charlotte Platner; Yogen Saunthararajah; John F Tisdale
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

Review 9.  Progresses towards safe and efficient gene therapy vectors.

Authors:  Sergiu Chira; Carlo S Jackson; Iulian Oprea; Ferhat Ozturk; Michael S Pepper; Iulia Diaconu; Cornelia Braicu; Lajos-Zsolt Raduly; George A Calin; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2015-10-13

10.  Characterization of the cHS4 insulator in mouse embryonic stem cells.

Authors:  Xi-Bin Lu; Yu-Han Guo; Wei Huang
Journal:  FEBS Open Bio       Date:  2020-03-19       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.